Clearpoint Neuro Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +27.5% | +25.1% | +28.4% | -0.4% | +52.5% | +14.4% | +27.0% | +26.1% | +16.6% | +31.0% | +17.8% | |
| – | +3.1% | +33.0% | +9.7% | -16.1% | +62.0% | -5.9% | +39.6% | +35.6% | +47.3% | +18.6% | +16.4% | |
| – | +55.4% | +19.2% | +44.2% | +9.8% | +47.9% | +25.4% | +22.0% | +21.6% | +0.6% | +40.5% | +18.7% | |
| – | -40.6% | +34.3% | +7.1% | -17.9% | +21.6% | +66.8% | +98.1% | +17.4% | +7.5% | +5.8% | +12.1% | |
| – | +4.1% | -49.9% | -3.4% | +6.9% | -0.5% | +22.5% | +51.8% | +20.2% | +22.3% | +2.1% | +37.5% | |
| – | -8.9% | +2.6% | +2.1% | -6.0% | +16.7% | +29.2% | +59.7% | +21.9% | +20.8% | +7.8% | +20.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +23.9% | -16.0% | -17.7% | +12.3% | -2.6% | +51.2% | -32.6% | -91.7% | +376.5% | +34.2% | +361.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -38.6% | -14.5% | -30.3% | -92.7% | +1,390.7% | +141.2% | -60.9% | -88.7% | +1,151.6% | -1,567.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.